Initial studies revealed increased podocyte expression of Angptl4 in human and experimental MCD, transient up-regulation after the onset of proteinuria in experimental membranous nephropathy (MN), and no change in podocyte expression in non-HIV collapsing glomerulopathy (CG) and FSGS [80]. Here, ANGPTL4 is linked to focal segmental glomerulosclerosis.